NDC 63833-765 - HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human)
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63833-765
- Package NDCs from labels
- 63833-765-18, 63833-765-19, 63833-765-15, 63833-765-53, 63833-765-54, 63833-765-55
- Manufacturer
- CSL Behring GmbH
- Effective date
- 2022-02-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human) - CSL Behring GmbH | CSL Behring GmbH | 2022-02-04 | PLASMA DERIVATIVE |
| Berinert - CSL Behring GmbH | CSL Behring GmbH | 2021-09-21 | PLASMA DERIVATIVE |
| Humate-P - CSL Behring GmbH | CSL Behring GmbH | 2020-08-17 | PLASMA DERIVATIVE |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63833-765 | BERINERT (HUMAN C1-ESTERASE INHIBITOR) KIT [CSL BEHRING GMBH] | 33 | Unmatched | 20210928_8ea0c7fe-da9d-4218-a080-0509e09bedc6.zip |
| 63833-765 | HUMATE-P (ANTIHEMOPHILIC FACTOR/VON WILLEBRAND FACTOR COMPLEX (HUMAN)) KIT [CSL BEHRING GMBH] | 16 | Unmatched | 20200826_c5f4b63b-8d8b-45b3-b530-2f1c32a1b852.zip |
| 63833-765 | HAEGARDA C1 ESTERASE INHIBITOR SUBCUTANEOUS (HUMAN) (HUMAN C1-ESTERASE INHIBITOR) KIT [CSL BEHRING GMBH] | 8 | Unmatched | 20220831_e270ad38-adc4-4ed5-88e3-943b93d20a57.zip |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TIS-U-SOL | SODIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, SODIUM PHOSPHATE, AND POTASSIUM PHOSPHATE | Baxter Healthcare Corporation | 9da4121f-d62d-4da4-8dfb-0494da16015f | 2014-02-21 | 451W47IQ8X | |
| Ringers | SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, | Baxter Healthcare Corporation | e1953d54-818d-46a6-8532-518ebae6d84e | 2012-06-13 | 451W47IQ8X | |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | Baxter Healthcare Corporation | f09f80bf-2f8b-4420-865d-aec2d5e5cd4d | 2012-06-12 | 451W47IQ8X | |
| 80ddcb9a-9526-4911-b7dc-7833c387a591 | c5f4b63b-8d8b-45b3-b530-2f1c32a1b852 | 2010-01-14 | Warnings, Adverse reactions | c5f4b63b-8d8b-45b3-b530-2f1c32a1b852 | ||
| 249c9738-7dfa-4f18-8330-be14437da235 | 8ea0c7fe-da9d-4218-a080-0509e09bedc6 | 2009-11-10 | Warnings, Adverse reactions | 8ea0c7fe-da9d-4218-a080-0509e09bedc6 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.